ArticleCureus2026
Melorheostosis: A Case Report on the Atypical Clinical Presentation and Management of a Rare Sclerosing Bone Disease.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melorheostosis, also known as Leri disease, is an exceptionally rare mixed sclerosing bone dysplasia of mesodermal origin, with a global prevalence below one per million individuals. It is characterized by progressive cortical and medullary hyperostosis following a sclerotomal distribution, producing the pathognomonic radiographic "dripping candle wax" appearance. We report a 50-year-old woman with no relevant medical background who presented with insidious left lower extremity pain, diffuse limb swelling, local warmth, hyperpigmentation, and reduced range of motion. Radiographs demonstrated eccentric cortical hyperostosis of the left tibia and fibula. Laboratory findings were entirely within normal limits, and tibial biopsy disclosed hyalinized collagen fibers with dystrophic calcifications. This case is notable for its late-onset presentation and monomelic distribution, contrasting with the early-onset course more commonly described. The patient achieved satisfactory outcomes through a conservative multimodal strategy combining celecoxib and structured physical therapy, with pain declining to 1/10 on the Visual Analogue Scale alongside meaningful functional recovery. This report highlights the importance of integrating clinical, imaging, and histopathological data, and reinforces the value of individualized, multidisciplinary management in this challenging condition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.